These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23332968)

  • 1. Cost-effectiveness and future implications for cardiovascular imaging.
    Shaw LJ
    Can J Cardiol; 2013 Mar; 29(3):350-7. PubMed ID: 23332968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular imaging: new directions in an evolving landscape.
    Dwivedi G; Chan KL; Friedrich MG; Beanlands RS
    Can J Cardiol; 2013 Mar; 29(3):257-9. PubMed ID: 23439017
    [No Abstract]   [Full Text] [Related]  

  • 3. Rising costs of medical imaging spur debate.
    Rowan K
    J Natl Cancer Inst; 2008 Dec; 100(23):1665-7. PubMed ID: 19033570
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic imaging at its centennial: the past, the present and the future.
    Doris CI
    CMAJ; 1995 Nov; 153(9):1297-300. PubMed ID: 7497392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
    Patel MR; Bailey SR; Bonow RO; Chambers CE; Chan PS; Dehmer GJ; Kirtane AJ; Wann LS; Ward RP
    J Am Coll Cardiol; 2012 May; 59(22):1995-2027. PubMed ID: 22578925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis.
    Mansueto M; Grimaldi A; Mangili G; Picchio M; Giovacchini G; Viganò R; Messa C; Fazio F
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):612-9. PubMed ID: 19549284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating patient-centered outcomes in the analysis of cost-effectiveness: imaging strategies for renovascular hypertension.
    Carlos RC; Axelrod DA; Ellis JH; Abrahamse PH; Fendrick AM
    AJR Am J Roentgenol; 2003 Dec; 181(6):1653-61. PubMed ID: 14627591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence, appropriateness, and technology assessment in cardiology: a case study of computed tomography.
    Redberg RF
    Health Aff (Millwood); 2007; 26(1):86-95. PubMed ID: 17211017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization management of cardiovascular imaging pre-certification and appropriateness.
    Hendel RC
    JACC Cardiovasc Imaging; 2008 Mar; 1(2):241-8. PubMed ID: 19356433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications and software techniques for integrated cardiac multimodality imaging.
    Slomka PJ; Berman DS; Germano G
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):27-41. PubMed ID: 18095905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economics of cardiovascular disease in the United States.
    Chen J; Rizzo JA
    Crit Care Clin; 2012 Jan; 28(1):77-88, vi. PubMed ID: 22123100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The year in cardiac imaging.
    Gibbons RJ; Araoz PA; Williamson EE
    J Am Coll Cardiol; 2011 Apr; 57(17):1721-34. PubMed ID: 21511108
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo tracking in cardiac stem cell-based therapy.
    Hoshino K; Ly HQ; Frangioni JV; Hajjar RJ
    Prog Cardiovasc Dis; 2007; 49(6):414-20. PubMed ID: 17498521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of diagnostic medical imaging.
    Bradley D; Bradley KE
    N C Med J; 2014; 75(2):121-5. PubMed ID: 24663134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving high-value cardiac imaging: challenges and opportunities.
    Wiener DH
    J Am Soc Echocardiogr; 2014 Jan; 27(1):1-7. PubMed ID: 24094554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying favorable-value cardiovascular health services.
    Braithwaite RS; Mentor SM
    Am J Manag Care; 2011 Jun; 17(6):431-8. PubMed ID: 21756013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding value in imaging: what is appropriate?
    Gibbons RJ
    J Nucl Cardiol; 2008; 15(2):178-85. PubMed ID: 18371588
    [No Abstract]   [Full Text] [Related]  

  • 18. Opportunities, challenges, and caveats of successful molecular imaging of cardiovascular diseases.
    Levkau B
    Basic Res Cardiol; 2008 Mar; 103(2):79-81. PubMed ID: 18324362
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular diseases as target for imaging.
    Graf K; Gräfe M; Fleck E
    Basic Res Cardiol; 2008 Mar; 103(2):82-6. PubMed ID: 18324363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based risk assessment in noninvasive imaging.
    Shaw LJ; Iskandrian AE; Hachamovitch R; Germano G; Lewin HC; Bateman TM; Berman DS
    J Nucl Med; 2001 Sep; 42(9):1424-36. PubMed ID: 11535736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.